Coalition Blames Slow Judicial Process and Parallel Drug Importation Program For Fake Drugs In Philippines
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The Coalition Against Fake Medicines, a group of multisectoral representatives in the healthcare industry, including pharmacists, retailers, and generics companies in the Philippines, recently called the country's slow judicial process a major factor in the rise of fake medicines, and said the government's parallel drug importation program under the Cheap Medicine Act partly helps counterfeits enter the country